$1.58
7.60% yesterday
NYSE, Nov 15, 10:00 pm CET
ISIN
US00857U1079
Symbol
AGL

Agilon Health Inc Target price 2024 - Analyst rating & recommendation

Agilon Health Inc Classifications & Recommendation:

Buy
17%
Hold
67%
Sell
17%

Agilon Health Inc Price Target

Target Price $3.39
Price $1.58
Potential
Number of Estimates 14
14 Analysts have issued a price target Agilon Health Inc 2025 . The average Agilon Health Inc target price is $3.39. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 18 analysts: 3 Analysts recommend Agilon Health Inc to buy, 12 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Agilon Health Inc stock has an average upside potential 2025 of . Most analysts recommend the Agilon Health Inc stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 4.32 6.05
59.38% 40.13%
EBITDA Margin -4.91% -2.21%
27.53% 54.96%
Net Margin -5.06% -3.83%
27.90% 24.28%

17 Analysts have issued a sales forecast Agilon Health Inc 2024 . The average Agilon Health Inc sales estimate is

$6.0b
Unlock
. This is
8.12% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.1b 8.48%
Unlock
, the lowest is
$6.0b 7.49%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $4.3b 59.38%
2024
$6.0b 40.13%
Unlock
2025
$6.8b 12.68%
Unlock
2026
$7.9b 16.32%
Unlock
2027
$8.5b 7.42%
Unlock
2028
$9.9b 15.93%
Unlock

14 Analysts have issued an Agilon Health Inc EBITDA forecast 2024. The average Agilon Health Inc EBITDA estimate is

$-134m
Unlock
. This is
58.36% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-39.7m 87.62%
Unlock
, the lowest is
$-160m 50.05%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-212m 103.26%
2024
$-134m 36.91%
Unlock
2025
$-63.6m 52.38%
Unlock
2026
$21.4m 133.68%
Unlock
2027
$51.7m 141.06%
Unlock
2028
$100.0m 93.51%
Unlock

EBITDA Margin

2023 -4.91% 27.53%
2024
-2.21% 54.96%
Unlock
2025
-0.93% 57.92%
Unlock
2026
0.27% 129.03%
Unlock
2027
0.61% 125.93%
Unlock
2028
1.01% 65.57%
Unlock

5 Agilon Health Inc Analysts have issued a net profit forecast 2024. The average Agilon Health Inc net profit estimate is

$-232m
Unlock
. This is
31.39% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-150m 55.58%
Unlock
, the lowest is
$-268m 20.73%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-218m 103.85%
2024
$-232m 6.15%
Unlock
2025
$-156m 32.73%
Unlock
2026
$-93.5m 40.03%
Unlock
2027
$-74.2m 20.70%
Unlock
2028
$-28.8m 61.11%
Unlock

Net Margin

2023 -5.06% 27.90%
2024
-3.83% 24.28%
Unlock
2025
-2.29% 40.21%
Unlock
2026
-1.18% 48.47%
Unlock
2027
-0.87% 26.27%
Unlock
2028
-0.29% 66.67%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.53 -0.56
103.85% 5.66%
P/E negative
EV/Sales 0.05

5 Analysts have issued a Agilon Health Inc forecast for earnings per share. The average Agilon Health Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.56
Unlock
. This is
31.71% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.36 56.10%
Unlock
, the lowest is
$-0.65 20.73%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.53 103.85%
2024
$-0.56 5.66%
Unlock
2025
$-0.38 32.14%
Unlock
2026
$-0.23 39.47%
Unlock
2027
$-0.18 21.74%
Unlock
2028
$-0.07 61.11%
Unlock

P/E ratio

Current -1.92 96.31%
2024
-2.81 46.35%
Unlock
2025
-4.17 48.40%
Unlock
2026
-6.96 66.91%
Unlock
2027
-8.78 26.15%
Unlock
2028
-22.57 157.06%
Unlock

Based on analysts' sales estimates for 2024, the Agilon Health Inc stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.05 94.85%
2024
0.05 2.00%
Unlock
2025
0.04 11.22%
Unlock
2026
0.04 14.02%
Unlock
2027
0.03 6.95%
Unlock
2028
0.03 13.79%
Unlock

P/S ratio

Current 0.12 89.39%
2024
0.11 7.56%
Unlock
2025
0.10 11.25%
Unlock
2026
0.08 14.03%
Unlock
2027
0.08 6.94%
Unlock
2028
0.07 13.74%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today